These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32058624)

  • 1. Expression of long noncoding RNAs in cancer-associated fibroblasts linked to patient survival in ovarian cancer.
    Colvin EK; Howell VM; Mok SC; Samimi G; Vafaee F
    Cancer Sci; 2020 May; 111(5):1805-1817. PubMed ID: 32058624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis.
    Vafaee F; Colvin EK; Mok SC; Howell VM; Samimi G
    Sci Rep; 2017 Sep; 7(1):10374. PubMed ID: 28871211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression.
    Guo Q; Cheng Y; Liang T; He Y; Ren C; Sun L; Zhang G
    Sci Rep; 2015 Dec; 5():17683. PubMed ID: 26631459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential long noncoding RNAs expression in cancer-associated fibroblasts of non-small-cell lung cancer.
    Teng C; Huang G; Luo Y; Pan Y; Wang H; Liao X; Li Y; Yang J
    Pharmacogenomics; 2019 Feb; 20(3):143-153. PubMed ID: 30808275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Long Non-Coding RNAs in Ovarian Cancer.
    Nikpayam E; Tasharrofi B; Sarrafzadeh S; Ghafouri-Fard S
    Iran Biomed J; 2017 Jan; 21(1):3-15. PubMed ID: 27664137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CAF-related lncRNAs at the pan-cancer level represents a potential carcinogenic risk.
    Wang M; Jiang M; Xie A; Zhang N; Xu Y
    Hum Mol Genet; 2024 Jun; 33(12):1064-1073. PubMed ID: 38507061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer.
    Worku T; Bhattarai D; Ayers D; Wang K; Wang C; Rehman ZU; Talpur HS; Yang L
    Cell Physiol Biochem; 2017; 44(3):948-966. PubMed ID: 29179183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
    Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
    J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer.
    Zhao L; Ji G; Le X; Wang C; Xu L; Feng M; Zhang Y; Yang H; Xuan Y; Yang Y; Lei L; Yang Q; Lau WB; Lau B; Chen Y; Deng X; Yao S; Yi T; Zhao X; Wei Y; Zhou S
    Cancer Res; 2017 Mar; 77(6):1369-1382. PubMed ID: 28087599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
    Xu L; Wu Y; Che X; Zhao J; Wang F; Wang P; Qu X; Liu Y; Li Z
    DNA Cell Biol; 2019 Dec; 38(12):1519-1528. PubMed ID: 31657627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
    Fang L; Wang H; Li P
    Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.
    Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y
    Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential prognostic TF-associated lncRNAs for predicting survival in ovarian cancer.
    Guo Q; He Y; Sun L; Kong C; Cheng Y; Wang P; Zhang G
    J Cell Mol Med; 2019 Mar; 23(3):1840-1851. PubMed ID: 30549251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
    Chen Y; Bi F; An Y; Yang Q
    J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer.
    Lu YM; Wang Y; Liu SQ; Zhou MY; Guo YR
    Oncol Rep; 2018 Nov; 40(5):2964-2976. PubMed ID: 30132558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
    Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
    J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA HOTTIP is a significant indicator of ovarian cancer prognosis and enhances cell proliferation and invasion.
    Zou T; Wang PL; Gao Y; Liang WT
    Cancer Biomark; 2019; 25(2):133-139. PubMed ID: 30452402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer.
    Lou Y; Jiang H; Cui Z; Wang X; Wang L; Han Y
    Int J Mol Med; 2018 Jul; 42(1):91-104. PubMed ID: 29577163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.